CTOR vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

CTOR

31.0
AI Score
VS
CTOR Wins

NIVF

29.0
AI Score

Investment Advisor Scores

CTOR

31score
Recommendation
SELL

NIVF

29score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CTOR NIVF Winner
Revenue 7.11M 4.73M CTOR
Net Income -41.07M 9.88M NIVF
Gross Margin 77.3% 20.2% CTOR
Net Margin -578.0% 209.0% NIVF
Operating Income -42.58M -10.73M NIVF
ROE -101.7% 37.1% NIVF
ROA -36.6% 30.2% NIVF
Total Assets 112.09M 32.72M CTOR
Cash 16.56M 758,621 CTOR
Current Ratio 0.73 3.12 NIVF

Relative Price Performance (Last 90 Days)

CTOR 1M: +13.1% · 3M: +32.5% NIVF 1M: +102.4% · 3M: +84.3%

Current Technical Phase

CTOR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 65

RSI (14): 64.8 · Price: $0.92

NIVF

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.3% over 20 days), RSI 60

RSI (14): 59.7 · Price: $1.06

Fundamentals Snapshot

Metric CTOR NIVF
Market Cap
Forward P/E 9.2 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.7% 0.2%
Operating Margin -6.0% -3.5%
EPS -0.46 328.32
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CTOR is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.